Evidence map›Paper›PMID 32884364›Full record

ArticleInternational medical case reports journal2020

Tamoxifen Induced Pachychoroid Pigment Epitheliopathy with Reversible Changes After Drug Discontinuation.

Fariba Ghassemi, Babak Masoomian, Alireza Khodabandeh, Elias Khalili Pour, Fatemeh Bazvand, Hamid Riazi-Esfahani

Open access · goldAbstract readCase Reports
In one paragraph

Article in International medical case reports journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fariba GhassemiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-9423-9650
Babak MasoomianEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-2249-2072
Alireza KhodabandehEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-3957-7515
Elias Khalili PourEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-8123-4375
Fatemeh BazvandEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-9720-2028
Hamid Riazi-EsfahaniEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-2277-398X
Farabi Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of breast cancer with clinically significant retinal toxicity induced by 7 years' Tamoxifen consumption in which patient's visual acuity and paraclinical findings remarkably improved after drug discontinuation. A 49-year-old woman with a history of breast cancer and Tamoxifen consumption was referred to our clinic for evaluation and treatment of gradual and progressive decrease visual acuity of both eyes (more prominent in right eye). Funduscopy showed bilateral macular pigmentary changes, with diffused tiny yellow crystals and reduced macular tessellation. On spectral-domain optical coherence tomography (SD-OCT), there was retinal pigment epithelium (RPE) abnormality and ellipsoid zone discontinuity accompanied by retinal thinning and choroidal thickness that was more prominent in the right eye. One year after discontinuation of the drug, visual acuity was significantly improved and SD-OCT revealed some surprising recoveries in the photoreceptor layers especially in her right eye.

Indexed as

breast cancerpachychoroidretinal toxicitytamoxifen retinopathy

Identifiers

PMID32884364
PMCPMC7434374
OpenAlexW3044385506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.